<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Endometriosis of the bladder and ureter</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Endometriosis of the bladder and ureter</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Endometriosis of the bladder and ureter</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nicola Berlanda, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paolo Vercellini, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Luigi Fedele, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tommaso Falcone, MD, FRCSC, FACOG</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H30390246"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Endometriosis is defined as endometrial glands and stroma at extrauterine sites. These ectopic endometrial implants are typically located in the pelvis but can occur throughout the body. Urinary tract endometriosis refers to endometriotic implants of the bladder, ureter, kidney, and urethra. In women with urinary tract endometriosis, the bladder and ureter are most commonly affected.</p><p>This topic will review the clinical presentation, diagnosis, and management of endometriosis of the bladder and ureter. General principles of the treatment of endometriosis, as well as endometriosis of the rectovaginal septum, bowel, and thorax, are presented separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7384.html" rel="external">"Endometriosis in adults: Pathogenesis, epidemiology, and clinical impact"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7383.html" rel="external">"Endometriosis: Treatment of pelvic pain"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16673.html" rel="external">"Endometriosis: Surgical management of pelvic pain"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14189.html" rel="external">"Endometriosis: Clinical manifestations and diagnosis of rectovaginal or bowel disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6687.html" rel="external">"Clinical features, diagnostic approach, and treatment of adults with thoracic endometriosis"</a>.)</p><p></p><p>In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transmasculine and gender-expansive individuals.</p><p class="headingAnchor" id="H17036461"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The etiology of endometriosis of the urinary tract is not clear. General theories of endometriosis include retrograde menstruation, lymphatic or hematogenous dissemination of endometrial cells, coelomic metaplasia, spread of endometrium-derived stem/progenitor cells, and altered genetic or immune factors [<a href="#rid1">1-7</a>]. Additionally, endometriosis appears to be iatrogenic in some women. (See  <a class="medical medical_review" href="/d/html/7384.html" rel="external">"Endometriosis in adults: Pathogenesis, epidemiology, and clinical impact", section on 'Pathogenesis'</a> and  <a class="medical medical_review" href="/d/html/5489.html" rel="external">"Uterine adenomyosis"</a> and <a class="local">'Special populations'</a> below.)</p><p>Anatomic structures of the pelvis may provide sheltered pockets that protect ectopic endometrial cells from the usual peritoneal clearance mechanisms and allow endometrial implants to develop [<a href="#rid7">7</a>]. This shelter effect may explain why bladder endometriosis is not typically seen in women with a retroverted uterus, as these women do not have a protected anterior space to facilitate growth of ectopic endometrial cells. Similarly, the sigmoid colon creates a shelter on the left side of the pelvis, which may explain why ureteral endometriosis is found more frequently on the left [<a href="#rid8">8-10</a>].</p><p class="headingAnchor" id="H29778329"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>Determining the prevalence of urinary tract endometriosis (including both bladder and ureteral endometriosis) in the general population is challenging because up to 50 percent of women with endometriosis may be asymptomatic [<a href="#rid11">11</a>]. Of women diagnosed with pelvic endometriosis, approximately 1 percent have urinary tract endometriosis, most commonly bladder endometriosis [<a href="#rid7">7,12</a>]. Endometriosis of the ureter is rare, with an estimated prevalence of 0.1 percent. However, in the subpopulation of women with deeply infiltrating endometriosis, urinary tract endometriosis has been diagnosed in up to 20 to 50 percent [<a href="#rid13">13-19</a>]. These wide ranges may reflect referral patterns rather than true disease prevalence. (See  <a class="medical medical_review" href="/d/html/7384.html" rel="external">"Endometriosis in adults: Pathogenesis, epidemiology, and clinical impact", section on 'Epidemiology'</a>.)</p><p>Among women with urinary tract endometriosis, the prevalence of disease at specific sites is [<a href="#rid20">20-22</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Bladder – 85 to 90 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Ureter – 10 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Kidney – 4 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Urethra – 2 percent</p><p></p><p class="headingAnchor" id="H30390253"><span class="h1">BLADDER ENDOMETRIOSIS</span></p><p class="headingAnchor" id="H947280773"><span class="h2">Definition</span><span class="headingEndMark"> — </span>Bladder endometriosis is an endometriotic lesion that infiltrates the detrusor muscle and can be either partial or full thickness [<a href="#rid7">7,23</a>].</p><p class="headingAnchor" id="H1679461292"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>Women with bladder endometriosis typically present with bladder pain or dysuria [<a href="#rid13">13,24-26</a>] but may have hematuria, urinary frequency, and urinary tract infection [<a href="#rid13">13,27</a>]. Urinary incontinence is rare (one case reported) [<a href="#rid27">27</a>]. Women are typically diagnosed with endometriosis, including bladder endometriosis, during their reproductive years, with a mean age of diagnosis of 33 years in one study of nearly 700 women with endometriosis (range of 20 to 57 years) [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/134970.html" rel="external">"Endometriosis: Clinical features, evaluation, and diagnosis", section on 'Clinical features'</a>.)</p><p>The symptom constellation of dysuria, urinary frequency and urgency, bladder infection, and hematuria is suggestive of bladder endometriosis in both women with known endometriosis and those who have not been diagnosed with endometriosis. However, this symptom constellation is more likely to reflect bladder endometriosis in women with known endometriosis compared with women who present with isolated urinary tract complaints. Rarely, bladder endometriosis can be asymptomatic and incidentally diagnosed at the time of a procedure for a different indication. The frequency of incidentally diagnosed bladder endometriosis is not known.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Known endometriosis</strong> – In women with previously diagnosed pelvic endometriosis, dysuria is the most common presenting symptom of bladder endometriosis, although urinary frequency and urinary urgency can still occur [<a href="#rid28">28</a>]. In one study of 213 women with deeply infiltrating endometriosis, dysuria occurred in nearly 70 percent of women with confirmed bladder endometriosis but only in 6 percent of women without bladder involvement [<a href="#rid19">19</a>]. Symptoms of bladder endometriosis may worsen with menses. Hematuria is rare, but when present, typically coincides with menses [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>No prior endometriosis</strong> – In women without a history of endometriosis, bladder endometriosis more commonly presents with nonspecific lower urinary tract symptoms including urinary urgency and frequency. The prevalence of previously undiagnosed endometriosis in women who present only with lower urinary tract symptoms is not known.</p><p></p><p class="headingAnchor" id="H1147551123"><span class="h2">Diagnostic evaluation</span><span class="headingEndMark"> — </span>A presumptive clinical diagnosis of bladder endometriosis can be made in women with known endometriosis who present with new symptoms of dysuria, voiding dysfunction, hematuria, and infections. The diagnostic evaluation includes a history, physical examination, limited laboratory testing, imaging, and cystourethroscopy.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>History and physical examination</strong> – Women with symptoms of bladder endometriosis are evaluated for symptoms and signs of both endometriosis and urinary tract disease. As women with bladder endometriosis often have endometriosis at multiple anatomic sites, the initial history and physical examination is the same for women suspected of having bladder endometriosis as for women with generalized symptoms of endometriosis [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/134970.html" rel="external">"Endometriosis: Clinical features, evaluation, and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory testing</strong> – For women with symptoms of dysuria, urinary urgency and frequency, or bladder pain, we perform a urinalysis to assess for infection or hematuria. Urine culture is done if infection is suspected. Women with hematuria proceed with cystourethroscopy. (See  <a class="medical medical_review" href="/d/html/3288.html" rel="external">"Diagnostic cystourethroscopy (cystoscopy) for gynecologic conditions", section on 'Indications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging</strong> – We perform a pelvic and renal ultrasound as part of the evaluation for bladder endometriosis. A consensus opinion from the International Deep Endometriosis Analysis (IDEA) group suggests specific assessment of the trigone, bladder base, and dome [<a href="#rid30">30</a>]. Although ultrasound cannot definitively diagnose endometriosis [<a href="#rid31">31,32</a>], findings suggestive of bladder endometriosis include nodules, abnormal adherence of adjacent structures in the vesicouterine pouch, and/or hydronephrosis  (<a class="graphic graphic_diagnosticimage graphicRef105235" href="/d/graphic/105235.html" rel="external">image 1</a>) [<a href="#rid33">33</a>]. Bladder ultrasound has been reported to have a bladder endometriosis detection rate as high as 97 percent and may detect partial-thickness lesions not visible with cystoscopy [<a href="#rid34">34-36</a>]. In addition, the examiner can use the ultrasound probe to assess organ immobility and elicited pain, both of which suggest other foci of deeply infiltrating endometriosis [<a href="#rid37">37,38</a>]. (See  <a class="medical medical_review" href="/d/html/7384.html" rel="external">"Endometriosis in adults: Pathogenesis, epidemiology, and clinical impact"</a>.)</p><p></p><p class="bulletIndent1">Hydronephrosis is uncommon in women with bladder nodules because the ureteral openings are not typically obstructed. Women who are diagnosed with bladder lesions and hydronephrosis undergo additional radiologic assessment of the ureter. In our practice, we request a computed tomography (CT) urogram. (See  <a class="medical medical_review" href="/d/html/7174.html" rel="external">"Clinical manifestations and diagnosis of urinary tract obstruction (UTO) and hydronephrosis", section on 'High suspicion for UTO: Diagnostic testing'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cystourethroscopy</strong> – For women with a bladder nodule seen on imaging or hematuria, we perform cystourethroscopy to biopsy the lesion, rule out malignancy, and measure the distance from the lesion to the ureteral meatus [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/d/html/3288.html" rel="external">"Diagnostic cystourethroscopy (cystoscopy) for gynecologic conditions", section on 'Indications'</a>.)</p><p></p><p class="bulletIndent1">Typically, vesical endometriosis appears on cystourethroscopy as edematous, bluish submucosal lesions that are located posterior to the trigone or on the dome  (<a class="graphic graphic_picture graphicRef70190" href="/d/graphic/70190.html" rel="external">picture 1</a>). The lesions can be large and multiple but are often single, averaging approximately 1 cm in size [<a href="#rid29">29</a>]. Endometriotic bladder nodules up to 5 cm in size have been reported [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1">In addition, we assess the distance of the lesion(s) to the ureteral openings to determine whether removal of the lesion(s) will require ureteral resection and reimplantation with ureteroneocystostomy [<a href="#rid39">39,40</a>]. Women who have undergone prior trigone resection are at increased risk of having nodules in close proximity with the trigone or ureteral orifices. If the caudal border of the endometriotic lesion is less than 2 cm from the interureteric ridge, ureteroneocystostomy is typically performed [<a href="#rid7">7</a>]. (See <a class="local">'Ureteroneocystostomy'</a> below.)</p><p></p><p class="bulletIndent1">Lesions that are identified on pelvic ultrasound but not visible at time of cystourethroscopy are presumably intramural and are evaluated with magnetic resonance imaging (MRI) [<a href="#rid41">41-43</a>]. MRI provides information on the extent of disease that aids in surgical planning and counseling of the patient.</p><p></p><p class="headingAnchor" id="H61222869"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>Endometriosis is a histologic diagnosis of tissue resected during cystoscopy or laparoscopy [<a href="#rid44">44</a>]. Biopsy is also necessary to exclude malignancy.</p><p class="headingAnchor" id="H61222890"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>As the presenting symptoms of urinary tract endometriosis are often nonspecific urinary symptoms, other urinary tract abnormalities are excluded as part of the evaluation. Alternate causes of dysuria, voiding dysfunction, and bladder pain include urinary tract infection, interstitial cystitis/bladder pain syndrome, urinary tract stones, benign growths such as papilloma or angioma, and malignancy [<a href="#rid44">44</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urinary tract infection</strong> – Urinary tract infection is excluded with a negative urine culture. (See  <a class="medical medical_review" href="/d/html/8063.html" rel="external">"Acute simple cystitis in adult and adolescent females"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Interstitial cystitis/bladder pain syndrome (IC/BPS)</strong> – IC/BPS is a clinical diagnosis based upon symptoms such as bladder discomfort associated with bladder filling and pelvic tenderness on examination. IC/BPS is often a diagnosis of exclusion, once etiologies such as bladder endometriosis and malignancy have been ruled out. (See  <a class="medical medical_review" href="/d/html/8085.html" rel="external">"Interstitial cystitis/bladder pain syndrome: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urinary tract stones</strong> – Women with urinary tract stones most commonly present with pain that waxes and wanes in severity. Hematuria, gross or microscopic, can be present. Urinary tract stones are typically identified on noncontrast computed tomography or ultrasound studies. (See  <a class="medical medical_review" href="/d/html/7366.html" rel="external">"Kidney stones in adults: Diagnosis and acute management of suspected nephrolithiasis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bladder neoplasm</strong> – Bladder neoplasms can be benign or malignant. Cystoscopy with tissue biopsy can differentiate among papillomas, angiomas, malignancy, and endometriosis. (See  <a class="medical medical_review" href="/d/html/2989.html" rel="external">"Clinical presentation, diagnosis, and staging of bladder cancer"</a>.)</p><p></p><p class="headingAnchor" id="H17036840"><span class="h2">Treatment</span></p><p class="headingAnchor" id="H862717332"><span class="h3">Our approach</span><span class="headingEndMark"> — </span>Treatment of bladder endometriosis is aimed at resolving symptoms; asymptomatic women can be observed [<a href="#rid7">7</a>]. We begin with medical therapy, since this approach avoids the risk of surgical complications and treats pain symptoms associated with pelvic endometriosis. The disadvantages of medical therapy are that it must be continued until menopause (when endometriosis typically regresses) and that it is not effective in all women. We reserve surgery for women who have failed medical therapy, cannot receive medical therapy, or who wish to avoid chronic medical treatment. (See  <a class="medical medical_review" href="/d/html/7383.html" rel="external">"Endometriosis: Treatment of pelvic pain", section on 'Medical treatment options'</a>.)</p><p>The data comparing medical and surgical therapy are limited. One cohort study of women with deep dyspareunia from deeply infiltrating endometriosis (urinary and rectovaginal) reported that 60 percent of women treated medically were satisfied but nearly one-third of women had an inadequate response to medical therapy and required surgical management [<a href="#rid45">45</a>].</p><p>One exception to the above approach is the patient with both bladder endometriosis and hydronephrosis. We perform surgery as the primary treatment to prevent subsequent renal damage, similar to women with ureteral endometriosis. (See <a class="local">'Ureteral endometriosis'</a> below.)</p><p class="headingAnchor" id="H30390260"><span class="h3">Medical</span><span class="headingEndMark"> — </span>For women with vesical endometriosis, combined estrogen-progestin contraceptives, progestins, and gonadotropin releasing hormone agonists have all been associated with symptom reduction [<a href="#rid29">29,46</a>]. (See  <a class="medical medical_review" href="/d/html/7383.html" rel="external">"Endometriosis: Treatment of pelvic pain", section on 'Medical treatment options'</a>.)</p><p>We typically treat bladder endometriosis with combined hormonal contraceptives because they are easy to use, easy to obtain, low cost, and low risk [<a href="#rid47">47</a>]. We begin with a cyclic regimen of combined estrogen-progestin oral contraceptives (ie, three weeks of therapy followed by a placebo week). If perimenstrual symptoms do not resolve within 3 to 6 months of starting a cyclic regimen, we then switch to a continuous schedule for menstrual suppression. For women who prefer continuous menstrual suppression, we begin treatment with a continuous regimen rather than the cyclic regimen.</p><p>Women who are not candidates for or do not want estrogen-containing medications are treated with progestin-only methods such as pills, injection, implant, or intrauterine device. Patients select the method that best meets their dosing, contraceptive, and cost needs. (See  <a class="medical medical_review" href="/d/html/7383.html" rel="external">"Endometriosis: Treatment of pelvic pain", section on 'Progestins'</a>.)</p><p>Women who cannot use or do not respond to estrogen-progestin or progestin-only methods are offered a trial of gonadotropin releasing hormone agonists. These medications can be used with or without estrogen-progestin add-back therapy. (See  <a class="medical medical_review" href="/d/html/7416.html" rel="external">"Endometriosis: Long-term treatment with gonadotropin-releasing hormone agonists"</a>.)</p><p>Women whose symptoms improve with medical management continue the treatment until they desire pregnancy or reach menopause. For women whose symptoms do not respond to medical management within six months, we offer surgical treatment. (See <a class="local">'Surgical'</a> below.)</p><p class="headingAnchor" id="H30750173"><span class="h3">Surgical</span><span class="headingEndMark"> — </span>Surgical procedures for treatment of bladder endometriosis include laparoscopic shaving of serosal lesions and full thickness resection of deeply infiltrating lesions [<a href="#rid23">23,28,44,48-52</a>]. Most surgeries are performed laparoscopically, including with robotic assistance. Laparotomy can be required for women with extensive disease that cannot be optimally managed laparoscopically [<a href="#rid7">7</a>]. Nerve-sparing surgical approach is discussed in a related topic. (See  <a class="medical medical_review" href="/d/html/110323.html" rel="external">"Endometriosis: Treatment of rectovaginal and bowel disease", section on 'Nerve-sparing technique'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ureteral stent placement</strong> – First, we perform cystourethroscopy to evaluate the location of the ureteral orifices relative to the endometriosis lesions and place ureteral stents if there is a distance of less than 2 cm between the inferior border of the lesion and the interureteric ridge. While trial data do not support routine use of ureteral catheters for gynecologic surgery, we find them helpful in women who have lesions close to the ureteric orifice, a history of prior bladder surgery, or significant anatomic distortion. (See  <a class="medical medical_review" href="/d/html/15182.html" rel="external">"Placement and management of indwelling ureteral stents", section on 'Prophylactic'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lesion dissection and excision</strong> – Next, we perform operative laparoscopy to shave superficial serosal lesions off the bladder. To remove full thickness bladder lesions, we perform partial cystectomy to remove the entire nodule and prevent recurrence [<a href="#rid11">11,39,47</a>]. If the nodule is located on the bladder dome, preliminary dissection to fully access the lesion is not typically required. In contrast, if the lesion involves the posterior bladder or the vesical base, we dissect the vesicouterine space to mobilize the bladder from the uterus  (<a class="graphic graphic_picture graphicRef79226" href="/d/graphic/79226.html" rel="external">picture 2</a>). We continue the dissection below the caudal margin of the nodule to facilitate complete resection. The lesion is then excised with cold scissors or cautery  (<a class="graphic graphic_picture graphicRef76479" href="/d/graphic/76479.html" rel="external">picture 3</a>). An alternative technique is to perform the cystotomy and nodule resection through an operative cystoscope and then suture the bladder via conventional or robot-assisted laparoscopy [<a href="#rid53">53-56</a>].</p><p></p><p class="bulletIndent1">In addition to dissection of the vesicouterine space, resection of the underlying myometrium appears to prevent recurrent symptoms when the bladder is coapted to the uterus. In a series of 33 women with endometriotic lesions at the bladder base, the recurrence rate was significantly lower in women who had concomitant myometrial resection compared with those who did not (7 versus 37 percent) [<a href="#rid57">57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ureter reimplantation</strong> – For women with bladder lesions that are less than 2 cm away from the interureteric ridge, we perform ureteroneocystostomy to prevent ureteral obstruction or stricture. This procedure is typically done laparoscopically or robotically. (See <a class="local">'Ureteroneocystostomy'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Resection of all endometriosis</strong> – At the time of resection of bladder endometriosis, we inspect the entire pelvis and abdomen and resect all other endometriosis lesions. In one study of 75 women with deeply infiltrating bladder endometriosis, nearly two-thirds had additional deep lesions in the posterior pelvis [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/d/html/16673.html" rel="external">"Endometriosis: Surgical management of pelvic pain"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bladder closure</strong> – The bladder incision (from nodule resection or ureteroneocystostomy) is closed with two layers of transverse sutures  (<a class="graphic graphic_picture graphicRef76479" href="/d/graphic/76479.html" rel="external">picture 3</a>). In our practice, we use a double layer of running 2-0 polyglactin 910 sutures. At the end of the procedure, the bladder is backfilled to confirm that the closure is watertight. Postoperatively, we leave a bladder catheter in place for 7 to 10 days to prevent fistula formation. (See  <a class="medical medical_review" href="/d/html/3276.html" rel="external">"Urinary tract injury in gynecologic surgery: Identification and management", section on 'Bladder injury'</a>.)</p><p></p><p class="headingAnchor" id="H66949034"><span class="h4">Complications</span><span class="headingEndMark"> — </span>Potential complications of bladder resection include vesical hematoma and vesicovaginal fistula [<a href="#rid40">40</a>]. Although urogenital fistula formation is uncommon after gynecologic surgery (less than 1 percent), surgical resection of endometriosis is a risk factor for formation. In one case series of 41 women who presented with vesicovaginal fistula following gynecologic surgery, 15 percent had undergone surgery for treatment of endometriosis [<a href="#rid58">58</a>]. (See  <a class="medical medical_review" href="/d/html/8071.html" rel="external">"Urogenital tract fistulas in females"</a> and  <a class="medical medical_review" href="/d/html/3288.html" rel="external">"Diagnostic cystourethroscopy (cystoscopy) for gynecologic conditions"</a>.)</p><p>General complications of gynecologic surgery are presented separately. (See  <a class="medical medical_review" href="/d/html/3289.html" rel="external">"Complications of gynecologic surgery"</a> and  <a class="medical medical_review" href="/d/html/88846.html" rel="external">"Complications of laparoscopic surgery"</a>.)</p><p class="headingAnchor" id="H66948735"><span class="h4">Prognosis</span><span class="headingEndMark"> — </span>Complete surgical removal of bladder endometriosis is associated with long-term control of symptoms [<a href="#rid40">40,57,59</a>]. In the largest case series of 75 women surgically treated for deeply infiltrating endometriosis of the bladder, none required repeat surgery, all women reported an improvement in pain symptoms, and 77 percent reported the pain improvement as "excellent" during mean follow-up of five years [<a href="#rid40">40</a>]. Complications included one vesicovaginal hematoma and one vesicovaginal fistula. As discussed above (see <a class="local">'Surgical'</a> above), complete resection of all residual disease minimizes the risk of recurrence [<a href="#rid57">57</a>].</p><p class="headingAnchor" id="H30390274"><span class="h1">URETERAL ENDOMETRIOSIS</span></p><p class="headingAnchor" id="H721957810"><span class="h2">Definition</span><span class="headingEndMark"> — </span>Ureteral endometriosis is endometriotic involvement of the ureter that can be either intrinsic or extrinsic. Intrinsic ureteral endometriosis is defined as an endometriosis lesion that develops within the ureter wall and results in fibrosis and proliferation of the ureteral muscularis. Rarely, the mucosa can also be involved, with a polypoid mass projecting into the lumen. Extrinsic ureteral endometriosis occurs when endometriosis involves the peritoneum overlying the ureter and causes compression of the ureteral wall. Both forms can cause ureteral stenosis and obstruction.</p><p class="headingAnchor" id="H17037257"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>While up to 50 percent of women with ureteral endometriosis are asymptomatic, approximately 25 percent present with colicky flank pain and up to 15 percent present with gross hematuria [<a href="#rid49">49</a>]. Additional nonspecific symptoms include dysmenorrhea and deep dyspareunia [<a href="#rid60">60</a>]. For asymptomatic women, the diagnosis is typically made at the time of pelvic surgery or imaging for other indications or when medical complications such as unexplained hypertension or renal failure develop [<a href="#rid16">16,61-63</a>].</p><p class="headingAnchor" id="H3071910012"><span class="h2">Diagnostic evaluation</span><span class="headingEndMark"> — </span>Women suspected of having ureteral endometriosis undergo a detailed history and physical examination, laboratory tests for renal function, and ultrasound evaluation of the urinary tract. For women with abnormal ultrasound findings, additional imaging can be needed.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>History and physical examination</strong> – Women with ureteral endometriosis often have diffuse disease. Thus, the history and physical examination of women with suspected ureteral endometriosis in the same as for women suspected of having generalized endometriosis. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory testing</strong> – Renal function may be impaired in women with ureteral endometriosis due to ureteral stenosis, hydroureter and hydronephrosis [<a href="#rid16">16,19,61-63</a>]. In one small retrospective study of women with surgically diagnosed, deeply infiltrating endometriosis, 43 percent (12 of 28 women) had decreased renal function, although the methods used to assess renal function were not specified [<a href="#rid64">64</a>]. For women with flank pain and/or hematuria, we also perform a urinalysis to exclude infection. Urine culture is done if infection is suspected. Women with hematuria proceed with cystoscopy. (See  <a class="medical medical_review" href="/d/html/7188.html" rel="external">"Diagnostic approach to adult patients with subacute kidney injury in an outpatient setting", section on 'Evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging</strong> – Pelvic and renal ultrasounds are performed to identify ureteral lesions, hydroureter, and hydronephrosis [<a href="#rid65">65</a>]. The ureter can be visualized from the renal pelvis to the anterior parametrium [<a href="#rid39">39</a>]. If hydronephrosis is present, the degree is graded based upon the appearance of the calices and renal pelvis and the thickness of renal parenchyma [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1">Diagnosing ureteral endometriosis with ultrasound requires a high index of suspicion because ureteral disease is not common, even among women with endometriosis, and women can be asymptomatic. As an example, one study of 750 women with endometriosis undergoing routine renal ultrasound reported ureterohydronephrosis in 23 women (3 percent), half of whom had no symptoms [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent1">In women with hydroureter or hydronephrosis, additional radiologic studies such as intravenous pyelography, computed tomography (CT) and magnetic resonance imaging can help identify the sites of stenosis and endometriosis lesions and thus aid surgical planning. In our practice, we order a urologic CT scan for all women with hydroureter or hydronephrosis because we find this test most helpful for surgical planning. (See  <a class="medical medical_review" href="/d/html/7174.html" rel="external">"Clinical manifestations and diagnosis of urinary tract obstruction (UTO) and hydronephrosis"</a>.)</p><p></p><p class="bulletIndent1">For women diagnosed with severe ureteral stenosis or obstruction on imaging, we perform preoperative renography to determine if the kidney is salvageable [<a href="#rid7">7</a>]. While the ability of renography to predict postoperative renal function is imperfect, renal function is expected to stabilize or improve if the preoperative glomerular filtration rate is ≥10 percent of the total normal glomerular filtration rate (ie, approximately ≥10 mL/minute) [<a href="#rid68">68</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cystourethroscopy</strong> – Women with suspected ureteral endometriosis lesions are also evaluated for bladder lesions as described above. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="headingAnchor" id="H154079406"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>Tissue biopsy and histologic confirmation is the gold standard for diagnosing ureteral endometriosis. Histologic evaluation can further differentiate between intrinsic or extrinsic ureteral endometriosis. While this distinction has pathogenetic significance, it does not impact clinical management because the difference cannot be determined preoperatively. In a study of 29 women with ureteral endometriosis, nearly 40 percent of lesions were intrinsic and approximately 60 percent were extrinsic [<a href="#rid69">69</a>].</p><p class="headingAnchor" id="H154079412"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of women with colicky flank pain and hematuria includes urinary tract infection, urinary tract stones, and neoplasms in addition to ureteral endometriosis. Steps to exclude these entities are presented above. (See <a class="local">'Differential diagnosis'</a> above.)</p><p>For women with asymptomatic hydronephrosis who are suspected of having ureteral endometriosis, the differential diagnosis includes all causes of acute or chronic kidney injury and is presented separately. (See  <a class="medical medical_review" href="/d/html/7174.html" rel="external">"Clinical manifestations and diagnosis of urinary tract obstruction (UTO) and hydronephrosis", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H64223165"><span class="h2">Surgery</span></p><p class="headingAnchor" id="H1246688325"><span class="h3">Choice of procedure</span><span class="headingEndMark"> — </span>Treatment of ureteral endometriosis (intrinsic and extrinsic) is primarily surgical [<a href="#rid7">7</a>]. Although cases of successful medical management of ureteral endometriosis have been reported [<a href="#rid70">70-72</a>], medical treatment does not typically resolve the fibrotic component of the lesion, which is largely responsible for the anatomic distortion and obstruction [<a href="#rid73">73,74</a>]. Additionally, the risks of poor medical response include worsened obstruction and decreased renal function. Therefore, in our practice, we treat the ureteral obstruction surgically as soon as the diagnosis is made  (<a class="graphic graphic_picture graphicRef54395" href="/d/graphic/54395.html" rel="external">picture 4</a>).</p><p>The goals of surgical treatment are to remove the endometriotic lesion(s), restore ureteral anatomy, and prevent loss of renal function [<a href="#rid16">16,40,75</a>]. Nerve-sparing surgical approach is discussed in a related topic. (See  <a class="medical medical_review" href="/d/html/110323.html" rel="external">"Endometriosis: Treatment of rectovaginal and bowel disease", section on 'Nerve-sparing technique'</a>.)</p><p>The main procedures include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ureterolysis</strong> – Surgical dissection of ureter from surrounding tissue, including fibrosis. This dissection is performed in a nerve-sparing manner whenever possible. (See  <a class="medical medical_review" href="/d/html/110323.html" rel="external">"Endometriosis: Treatment of rectovaginal and bowel disease", section on 'Nerve-sparing technique'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ureterectomy with ureteroureteral anastomosis</strong> – Removal of stenotic segment (ureterectomy) and reattachment of proximal and distal cut ureteral ends to each other (ureteroureteral anastomosis)  (<a class="graphic graphic_figure graphicRef110222" href="/d/graphic/110222.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ureteroneocystostomy</strong> – Resection of stenotic segment followed by reimplantation of the proximal ureter into the bladder dome  (<a class="graphic graphic_figure graphicRef110221" href="/d/graphic/110221.html" rel="external">figure 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Excision of all other endometriosis lesions.</strong></p><p></p><p>The stenotic portion of ureter can be managed by either ureterolysis alone, ureterolysis followed by resection with anastomosis (ureterectomy with ureteroureteral anastomosis), or ureterolysis, resection, and ureteroneocystostomy. The choice of procedure(s) is determined by the severity and location of disease  (<a class="graphic graphic_picture graphicRef54395" href="/d/graphic/54395.html" rel="external">picture 4</a>). Women with less extensive disease undergo more conservative surgery consisting of ureterolysis and resection of all other endometriosis implants. Although ureterolysis appears to have a higher restenosis rate compared with ureteroneocystostomy (8 versus 3 percent), the data are limited and do not justify performing a more morbid surgery when a less invasive procedure will restore renal function for more than 90 percent of women [<a href="#rid14">14,17,50,75-81</a>]. Women with moderate to severe disease often require radical surgery, including segmental ureterectomy with reanastomosis or ureteroneocystostomy, to remove advanced disease and restore normal anatomy [<a href="#rid82">82</a>]. For most women, surgery is performed laparoscopically, with or without robotic assistance, because of faster recovery compared with laparotomy [<a href="#rid8">8,60,76,77,83</a>]. We insert a ureteral stent any time we are operating directly on the ureter to minimize the risk of postoperative kinking and fistula formation.</p><p>Women who cannot undergo immediate surgical resection are at risk for continued renal injury. Therefore, we treat women whose surgery must be delayed with suppressive medical therapy (eg, hormonal suppression) and insert a ureteral stent. In such cases, we closely monitor renal function with ultrasound to assess the degree of hydronephrosis until definitive surgical resection can be performed.</p><p class="headingAnchor" id="H66948285"><span class="h4">Ureterolysis</span><span class="headingEndMark"> — </span>Ureterolysis is the first step of all ureteral procedures as it removes the endometriotic fibrotic tissue involving the ureter, mobilizes the ureter, and relieves the obstruction  (<a class="graphic graphic_picture graphicRef54395" href="/d/graphic/54395.html" rel="external">picture 4</a>) [<a href="#rid7">7</a>]. The peritoneum overlying the ureter is opened at the level of the pelvic brim, where both the ureter and peritoneum are rarely affected by endometriotic disease or associated fibrosis. The ureter is then exposed down to the level of the cardinal ligament. In women with healthy retroperitoneal tissue, this is done by blunt dissection. If endometriosis is present, we use cold or electrosurgical scissors to excise adjacent endometrial lesions. Removal of lesions can be difficult to achieve since endometriotic nodules can infiltrate the ureteral wall and often have no clear cleavage planes in relation to surrounding structures. Despite the challenge, we remove all lesions, rather than ablate them, because ablation increases the risk of ureteral fistula. We employ a nerve-sparing technique for the dissection. (See  <a class="medical medical_review" href="/d/html/110323.html" rel="external">"Endometriosis: Treatment of rectovaginal and bowel disease", section on 'Nerve-sparing technique'</a>.)</p><p>If endometriosis invades the ureteral adventitia (outer layer), more aggressive ureterolysis is necessary. This consists of cutting the adventitial sheath and removing the fibrosed surface while leaving the muscular layer intact. During the procedure, unintentional perforations of the ureteral lumen can be repaired with interrupted 4-0 polydioxanone sutures [<a href="#rid84">84</a>]. Of note, incisions in the ureteral adventitia can compromise the periureteral vascular supply and increase the risk of postoperative ureteral fistula [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H66948535"><span class="h4">Ureterectomy</span><span class="headingEndMark"> — </span>For women with documented ureteral stenosis and significant hydronephrosis, we perform ureterectomy of the affected segment after completion of ureterolysis. For ureters with lesions in the middle or upper third, we perform an ureteroureteral anastomosis  (<a class="graphic graphic_figure graphicRef110222" href="/d/graphic/110222.html" rel="external">figure 1</a>). When the ureteral lesion is in the distal third of the ureter, we perform ureteral resection and reimplantation (ureteroneocystostomy)  (<a class="graphic graphic_figure graphicRef110221" href="/d/graphic/110221.html" rel="external">figure 2</a>). (See <a class="local">'Ureteroneocystostomy'</a> below.)</p><p>As intraoperative criteria that predict restenosis have not been identified, the decision to perform the more invasive ureterectomy versus ureterolysis only is subjective, which makes comparison of study results difficult [<a href="#rid8">8</a>]. We believe that resection of the stenosed ureteral segment, with ureteroneocystostomy if indicated, minimizes the risk of stenosis recurrence [<a href="#rid50">50,78</a>]. This surgical decision is typically made with input from urologists as well.</p><p class="headingAnchor" id="H66948575"><span class="h4">Ureteroneocystostomy</span><span class="headingEndMark"> — </span>Since most ureteral lesions are located in the distal ureter, 3 to 4 cm above the vesicoureteral junction [<a href="#rid79">79</a>], ureteral resection with ureteroneocystostomy is typically performed to remove the stenotic segment and safely reimplant the ureter. In this technique, the ureter is incised proximal to the stricture and is reimplanted into the bladder, typically at the dome  (<a class="graphic graphic_figure graphicRef110221" href="/d/graphic/110221.html" rel="external">figure 2</a>). A bladder-psoas hitch can be required to achieve a tension-free anastomosis. An antireflux plasty of the bladder valve is performed to avoid ascending infections [<a href="#rid78">78,85</a>].</p><p class="headingAnchor" id="H66948589"><span class="h3">Resection of all endometriosis</span><span class="headingEndMark"> — </span>We remove all endometriotic foci that are in the vicinity of the ureters to prevent disease progression, future ureteral stenosis, and renal damage [<a href="#rid86">86</a>]. This includes lesions that are found incidentally at time of surgery and are proximal to, but do not directly impinge upon, the ureters. All other areas of endometriosis are treated as well. In a retrospective study of 96 women with histologically confirmed ureteral endometriosis, more than two-thirds had concomitant endometriosis of the ipsilateral ovary [<a href="#rid8">8</a>]. (See  <a class="medical medical_review" href="/d/html/16673.html" rel="external">"Endometriosis: Surgical management of pelvic pain"</a>.)</p><p class="headingAnchor" id="H66948621"><span class="h3">Complications</span><span class="headingEndMark"> — </span>In a review of 243 women treated for ureteral endometriosis, the cumulative surgical complication rate was 9 percent [<a href="#rid7">7</a>]. Procedures performed included ureterolysis (176 women), ureteral anastomosis (28 women), and ureteroneocystostomy (39 women). Major complications included persistence or recurrence of ureteral stenosis requiring repeat surgery (7.4 percent), ureteral or ureterovaginal fistula (1.6 percent), and hemoperitoneum (0.4 percent). For comparison, in the United States, estimates of urogenital fistula formation after gynecologic surgery range from less than 0.5 percent after simple hysterectomy to 10 percent after radical hysterectomy [<a href="#rid87">87-89</a>].</p><p>General complications of gynecologic surgery are presented separately. (See  <a class="medical medical_review" href="/d/html/3289.html" rel="external">"Complications of gynecologic surgery"</a> and  <a class="medical medical_review" href="/d/html/88846.html" rel="external">"Complications of laparoscopic surgery"</a>.)</p><p class="headingAnchor" id="H2478869401"><span class="h3">Prognosis</span><span class="headingEndMark"> — </span>The rate of persistent or recurrent ureteral stenosis appears to vary by type of surgical procedure. Compilation of ten case studies calculated the following cumulative ureteral restenosis rates by procedure [<a href="#rid14">14,17,50,75-81</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Ureterolysis alone – 8 percent (14 of 176)</p><p class="bulletIndent1"><span class="glyph">●</span>Ureterectomy with ureteroureteral anastomosis – 11 percent (3 of 28)</p><p class="bulletIndent1"><span class="glyph">●</span>Ureteroneocystostomy – 3 percent (1 of 39)</p><p></p><p>While the data suggest that ureterolysis alone and ureteroureteral anastomosis are associated with higher rates of persistent or recurrent stenosis compared with ureteroneocystostomy, definitive conclusions are limited by the small numbers of patients and the lack of comparative trial data.</p><p class="headingAnchor" id="H54442759"><span class="h1">SPECIAL POPULATIONS</span></p><p class="headingAnchor" id="H2475163187"><span class="h2">Combined bladder and ureteral endometriosis</span><span class="headingEndMark"> — </span>Women with both bladder and ureteral endometriosis are treated surgically to prevent renal injury resulting from ureteral involvement. However, small studies suggest the two processes do not typically occur in the same woman. As an example, in a group of 43 women with urinary tract endometriosis undergoing surgery at a specialty center, only 3 women (7 percent) had both bladder and ureteral involvement [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H2279681982"><span class="h2">Iatrogenic bladder endometriosis</span><span class="headingEndMark"> — </span>In some women, bladder endometriosis appears to be iatrogenic. Surgeries that disrupt the endometrium, such as cesarean delivery or transmural myomectomy, may spread endometrial tissue or include endometrial tissue in the closure [<a href="#rid3">3,90</a>]. In contrast to women with spontaneous endometriosis, women with iatrogenic endometriosis typically have isolated foci of endometriosis, often in the surgical scar [<a href="#rid7">7</a>]. Women with bladder endometriosis are managed as reviewed above, regardless of the cause. (See <a class="local">'Treatment'</a> above and  <a class="medical medical_review" href="/d/html/4459.html" rel="external">"Cesarean birth: Postoperative care, complications, and long-term sequelae", section on 'Scar complications'</a>.)</p><p class="headingAnchor" id="H855235640"><span class="h2">Incidental endometriosis</span><span class="headingEndMark"> — </span>We perform ureterolysis in women whose ureteral disease is incidentally discovered during other surgery. However, we defer more extensive ureteral procedures (eg, cutting of the ureteral adventitia or ureteral resection) if appropriate informed consent has not been obtained because of the increased risks of complications from more advanced dissection.</p><p class="headingAnchor" id="H3822214680"><span class="h2">Pregnancy</span><span class="headingEndMark"> — </span>The removal of bladder endometriosis is contraindicated in pregnant women because the increased pelvic blood flow during pregnancy increases the risk of hemorrhage. Although the relative position of the uterus to the bladder shifts during pregnancy, the gravid uterus does not facilitate development of tissue planes and resection of endometriotic lesions because these lesions are typically adherent to the surrounding tissue [<a href="#rid91">91</a>].</p><p class="headingAnchor" id="H254712964"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109439.html" rel="external">"Society guideline links: Endometriosis"</a>.)</p><p class="headingAnchor" id="H12144313"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15431.html" rel="external">"Patient education: Endometriosis (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/2174.html" rel="external">"Patient education: Endometriosis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H30390295"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – General theories of endometriosis include retrograde menstruation, lymphatic or hematogenous dissemination of endometrial cells, coelomic metaplasia, spread of endometrium-derived stem/progenitor cells, and altered genetic or immune factors. In addition, anatomic structures (eg, anteverted uterine fundus, sigmoid colon) of the pelvis may provide sheltered pockets that protect ectopic endometrial cells from the usual peritoneal clearance mechanisms and allow endometrial implants to develop. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence of urinary tract endometriosis</strong> – Of patients diagnosed with pelvic endometriosis, approximately 1 percent have urinary tract endometriosis, most commonly bladder endometriosis. Endometriosis of the ureter occurs in approximately 0.1 percent of women. However, in the subpopulation of women with deeply infiltrating endometriosis, urinary tract endometriosis has been diagnosed in up to 20 to 50 percent. These wide ranges may reflect referral patterns rather than true disease prevalence. (See <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bladder endometriosis</strong> – Bladder endometriosis is an endometriotic lesion that infiltrates the detrusor muscle and can be either partial or full thickness. Women with bladder endometriosis typically present with dysuria or with lower urinary tract symptoms such as urinary urgency and frequency.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluation</strong> – The diagnostic evaluation of women with suspected bladder endometriosis includes a history, physical examination, limited laboratory testing to exclude infection, imaging to evaluate for bladder lesions and hydronephrosis, and cystourethroscopy to assess for lesions and location relative to the ureteral orifices. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnosis</strong> – Bladder endometriosis is diagnosed by biopsy of lesions and/or visualization of lesions. Biopsy is typically necessary to exclude malignancy. (See <a class="local">'Definition'</a> above and <a class="local">'Clinical manifestations'</a> above and <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment options and selection</strong> – Treatment of bladder endometriosis is aimed at resolving symptoms; asymptomatic women can be observed. For most women with symptomatic bladder endometriosis, we suggest medical rather than surgical treatment (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). We reserve surgery for women who have failed or have contraindications to medical therapy, who wish to avoid chronic medical treatment, or who have hydronephrosis. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ureteral endometriosis</strong> – Ureteral endometriosis may be either within the ureteral wall (intrinsic) or involve the overlying peritoneum (extrinsic). More than one-half of women with ureteral endometriosis are asymptomatic; others present with colicky flank pain or gross hematuria. Both forms can cause ureteral stenosis and obstruction. Hydronephrosis in asymptomatic patients may result in silent loss of renal function. (See <a class="local">'Definition'</a> above and <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The diagnostic evaluation of women with suspected ureteral endometriosis includes a history, physical examination, laboratory testing to assess renal function and exclude urinary tract infection, and pelvic and renal ultrasounds to evaluate for ureteral lesions, hydroureter, and hydronephrosis. Cystourethroscopy is performed to exclude bladder lesions. Ureteral endometriosis is diagnosed by visualization and/or biopsy of lesions. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Treatment of ureteral endometriosis is surgical, since medical therapy has not been proven effective at relieving ureteral obstruction. For women with hydronephrosis in whom surgery must be delayed, we suggest a combination of medical therapy and insertion of a ureteral stent rather than either treatment alone or no treatment (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Choice of procedure'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The first step in surgical treatment of ureteral endometriosis is ureterolysis. Subsequent surgical management can include resection of a segment (ureterectomy) with anastomosis (ureteroureteral anastomosis  (<a class="graphic graphic_figure graphicRef110222" href="/d/graphic/110222.html" rel="external">figure 1</a>)) or with ureteral implantation into the bladder (ureteroneocystostomy  (<a class="graphic graphic_figure graphicRef110221" href="/d/graphic/110221.html" rel="external">figure 2</a>)). Lesions of the lower third of the ureter typically require ureteroneocystostomy. (See <a class="local">'Ureterolysis'</a> above and <a class="local">'Ureterectomy'</a> above and <a class="local">'Ureteroneocystostomy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The cumulative surgical complication rate after treatment of ureteral endometriosis has been reported as 9 percent. The most complications include persistence or recurrence of ureteral stenosis requiring repeat surgery (7.4 percent), ureteral or ureterovaginal fistula (1.6 percent), and hemoperitoneum (0.4 percent). (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The rate of restenosis appears to vary by ureteral procedure, but definitive conclusions are limited by the small sample size and lack of comparative trials. (See <a class="local">'Prognosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Donnez J, Spada F, Squifflet J, Nisolle M. Bladder endometriosis must be considered as bladder adenomyosis. Fertil Steril 2000; 74:1175.</a></li><li><a class="nounderline abstract_t">Fedele L, Piazzola E, Raffaelli R, Bianchi S. Bladder endometriosis: deep infiltrating endometriosis or adenomyosis? Fertil Steril 1998; 69:972.</a></li><li><a class="nounderline abstract_t">Buka NJ. Vesical endometriosis after cesarean section. Am J Obstet Gynecol 1988; 158:1117.</a></li><li><a class="nounderline abstract_t">Cruz Guerra NA, Linares Quevedo A, Cuesta Roca C, et al. [Bladder endometriosis in a patient with cesarean history]. Arch Esp Urol 2002; 55:194.</a></li><li><a class="nounderline abstract_t">Vercellini P, Frontino G, Pisacreta A, et al. The pathogenesis of bladder detrusor endometriosis. Am J Obstet Gynecol 2002; 187:538.</a></li><li><a class="nounderline abstract_t">Tosti C, Pinzauti S, Santulli P, et al. Pathogenetic Mechanisms of Deep Infiltrating Endometriosis. Reprod Sci 2015; 22:1053.</a></li><li><a class="nounderline abstract_t">Berlanda N, Vercellini P, Carmignani L, et al. Ureteral and vesical endometriosis. Two different clinical entities sharing the same pathogenesis. Obstet Gynecol Surv 2009; 64:830.</a></li><li><a class="nounderline abstract_t">Bosev D, Nicoll LM, Bhagan L, et al. Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive cases. J Urol 2009; 182:2748.</a></li><li><a class="nounderline abstract_t">Vercellini P, Pisacreta A, Pesole A, et al. Is ureteral endometriosis an asymmetric disease? BJOG 2000; 107:559.</a></li><li><a class="nounderline abstract_t">Vercellini P, Eskenazi B, Consonni D, et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update 2011; 17:159.</a></li><li><a class="nounderline abstract_t">Seracchioli R, Mabrouk M, Montanari G, et al. Conservative laparoscopic management of urinary tract endometriosis (UTE): surgical outcome and long-term follow-up. Fertil Steril 2010; 94:856.</a></li><li><a class="nounderline abstract_t">Donnez J, Brosens I. Definition of ureteral endometriosis? Fertil Steril 1997; 68:178.</a></li><li><a class="nounderline abstract_t">Gabriel B, Nassif J, Trompoukis P, et al. Prevalence and management of urinary tract endometriosis: a clinical case series. Urology 2011; 78:1269.</a></li><li><a class="nounderline abstract_t">Schneider A, Touloupidis S, Papatsoris AG, et al. Endometriosis of the urinary tract in women of reproductive age. Int J Urol 2006; 13:902.</a></li><li><a class="nounderline abstract_t">Maccagnano C, Pellucchi F, Rocchini L, et al. Ureteral endometriosis: proposal for a diagnostic and therapeutic algorithm with a review of the literature. Urol Int 2013; 91:1.</a></li><li><a class="nounderline abstract_t">Muñoz JL, Jiménez JS, Tejerizo A, et al. Rectosigmoid deep infiltrating endometriosis and ureteral involvement with loss of renal function. Eur J Obstet Gynecol Reprod Biol 2012; 162:121.</a></li><li><a class="nounderline abstract_t">Donnez J, Nisolle M, Squifflet J. Ureteral endometriosis: a complication of rectovaginal endometriotic (adenomyotic) nodules. Fertil Steril 2002; 77:32.</a></li><li><a class="nounderline abstract_t">Setälä M, Kössi J, Silventoinen S, Mäkinen J. The impact of deep disease on surgical treatment of endometriosis. Eur J Obstet Gynecol Reprod Biol 2011; 158:289.</a></li><li><a class="nounderline abstract_t">Knabben L, Imboden S, Fellmann B, et al. Urinary tract endometriosis in patients with deep infiltrating endometriosis: prevalence, symptoms, management, and proposal for a new clinical classification. Fertil Steril 2015; 103:147.</a></li><li><a class="nounderline abstract_t">ABESHOUSE BS, ABESHOUSE G. Endometriosis of the urinary tract: a review of the literature and a report of four cases of vesical endometriosis. J Int Coll Surg 1960; 34:43.</a></li><li><a class="nounderline abstract_t">Yohannes P. Ureteral endometriosis. J Urol 2003; 170:20.</a></li><li><a class="nounderline abstract_t">Dénes FT, Pompeo AC, Montelatto NI, Lopes RN. Ureteral endometriosis. Int Urol Nephrol 1980; 12:205.</a></li><li><a class="nounderline abstract_t">Kovoor E, Nassif J, Miranda-Mendoza I, Wattiez A. Endometriosis of bladder: outcomes after laparoscopic surgery. J Minim Invasive Gynecol 2010; 17:600.</a></li><li><a class="nounderline abstract_t">Sinaii N, Plumb K, Cotton L, et al. Differences in characteristics among 1,000 women with endometriosis based on extent of disease. Fertil Steril 2008; 89:538.</a></li><li><a class="nounderline abstract_t">Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ 2014; 348:g1752.</a></li><li><a class="nounderline abstract_t">Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014; 10:261.</a></li><li><a class="nounderline abstract_t">Leone Roberti Maggiore U, Ferrero S, Salvatore S. Urinary incontinence and bladder endometriosis: conservative management. Int Urogynecol J 2015; 26:159.</a></li><li><a class="nounderline abstract_t">STANLEY KE Jr, UTZ DC, DOCKERTY MB. CLINICALLY SIGNIFICANT ENDOMETRIOSIS OF THE URINARY TRACT. Surg Gynecol Obstet 1965; 120:491.</a></li><li><a class="nounderline abstract_t">Westney OL, Amundsen CL, McGuire EJ. Bladder endometriosis: conservative management. J Urol 2000; 163:1814.</a></li><li><a class="nounderline abstract_t">Guerriero S, Condous G, van den Bosch T, et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol 2016; 48:318.</a></li><li><a class="nounderline abstract_t">Bennett GL, Slywotzky CM, Cantera M, Hecht EM. Unusual manifestations and complications of endometriosis--spectrum of imaging findings: pictorial review. AJR Am J Roentgenol 2010; 194:WS34.</a></li><li><a class="nounderline abstract_t">Chway C, Flórez S, Muñoz MD, et al. The Diagnostic Accuracy of Transvaginal Ultrasound for Detection of Ureteral Involvement in Deep Infiltrating Endometriosis: A Systematic Review and Meta-Analysis. J Ultrasound Med 2024; 43:7.</a></li><li><a class="nounderline abstract_t">Goncalves MO, Dias JA Jr, Podgaec S, et al. Transvaginal ultrasound for diagnosis of deeply infiltrating endometriosis. Int J Gynaecol Obstet 2009; 104:156.</a></li><li><a class="nounderline abstract_t">Exacoustos C, Malzoni M, Di Giovanni A, et al. Ultrasound mapping system for the surgical management of deep infiltrating endometriosis. Fertil Steril 2014; 102:143.</a></li><li><a class="nounderline abstract_t">Hudelist G, Tammaa A, Aas-Eng MK, et al. Outcome of sonography-based minimally invasive surgery for deep infiltrating endometriosis of the ureter and urinary bladder - a retrospective cohort study. Acta Obstet Gynecol Scand 2018; 97:277.</a></li><li><a class="nounderline abstract_t">Ros C, de Guirior C, Rius M, et al. Accuracy of Transvaginal Ultrasound Compared to Cystoscopy in the Diagnosis of Bladder Endometriosis Nodules. J Ultrasound Med 2021; 40:1571.</a></li><li><a class="nounderline abstract_t">Guerriero S, Ajossa S, Gerada M, et al. Diagnostic value of transvaginal 'tenderness-guided' ultrasonography for the prediction of location of deep endometriosis. Hum Reprod 2008; 23:2452.</a></li><li><a class="nounderline abstract_t">Reid S, Lu C, Casikar I, et al. Prediction of pouch of Douglas obliteration in women with suspected endometriosis using a new real-time dynamic transvaginal ultrasound technique: the sliding sign. Ultrasound Obstet Gynecol 2013; 41:685.</a></li><li><a class="nounderline abstract_t">Berlanda N, Somigliana E, Frattaruolo MP, et al. Surgery versus hormonal therapy for deep endometriosis: is it a choice of the physician? Eur J Obstet Gynecol Reprod Biol 2017; 209:67.</a></li><li><a class="nounderline abstract_t">Chapron C, Bourret A, Chopin N, et al. Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions. Hum Reprod 2010; 25:884.</a></li><li><a class="nounderline abstract_t">Chamié LP, Blasbalg R, Gonçalves MO, et al. Accuracy of magnetic resonance imaging for diagnosis and preoperative assessment of deeply infiltrating endometriosis. Int J Gynaecol Obstet 2009; 106:198.</a></li><li><a class="nounderline abstract_t">Grasso RF, Di Giacomo V, Sedati P, et al. Diagnosis of deep infiltrating endometriosis: accuracy of magnetic resonance imaging and transvaginal 3D ultrasonography. Abdom Imaging 2010; 35:716.</a></li><li><a class="nounderline abstract_t">Busard MP, Mijatovic V, van Kuijk C, et al. Magnetic resonance imaging in the evaluation of (deep infiltrating) endometriosis: the value of diffusion-weighted imaging. J Magn Reson Imaging 2010; 32:1003.</a></li><li><a class="nounderline abstract_t">Nezhat CH, Malik S, Osias J, et al. Laparoscopic management of 15 patients with infiltrating endometriosis of the bladder and a case of primary intravesical endometrioid adenosarcoma. Fertil Steril 2002; 78:872.</a></li><li><a class="nounderline abstract_t">Vercellini P, Somigliana E, Consonni D, et al. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction. Hum Reprod 2012; 27:3450.</a></li><li><a class="nounderline abstract_t">Fedele L, Bianchi S, Montefusco S, et al. A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis. Fertil Steril 2008; 90:183.</a></li><li><a class="nounderline abstract_t">Leone Roberti Maggiore U, Ferrero S, Candiani M, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017; 71:790.</a></li><li><a class="nounderline abstract_t">Chapron C, Dubuisson JB. Laparoscopic management of bladder endometriosis. Acta Obstet Gynecol Scand 1999; 78:887.</a></li><li><a class="nounderline abstract_t">Comiter CV. Endometriosis of the urinary tract. Urol Clin North Am 2002; 29:625.</a></li><li><a class="nounderline abstract_t">Antonelli A, Simeone C, Zani D, et al. Clinical aspects and surgical treatment of urinary tract endometriosis: our experience with 31 cases. Eur Urol 2006; 49:1093.</a></li><li><a class="nounderline abstract_t">Pastor-Navarro H, Giménez-Bachs JM, Donate-Moreno MJ, et al. Update on the diagnosis and treatment of bladder endometriosis. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:949.</a></li><li><a class="nounderline abstract_t">Lousquy R, Borghese B, Chapron C. [Deep bladder endometriosis: how do I...to perform a laparoscopic partial cystectomy?]. Gynecol Obstet Fertil 2010; 38:697.</a></li><li><a class="nounderline abstract_t">Seracchioli R, Mannini D, Colombo FM, et al. Cystoscopy-assisted laparoscopic resection of extramucosal bladder endometriosis. J Endourol 2002; 16:663.</a></li><li><a class="nounderline abstract_t">Sener A, Chew BH, Duvdevani M, et al. Combined transurethral and laparoscopic partial cystectomy and robot-assisted bladder repair for the treatment of bladder endometrioma. J Minim Invasive Gynecol 2006; 13:245.</a></li><li><a class="nounderline abstract_t">Pang ST, Chao A, Wang CJ, et al. Transurethral partial cystectomy and laparoscopic reconstruction for the management of bladder endometriosis. Fertil Steril 2008; 90:2014.e1.</a></li><li><a class="nounderline abstract_t">Nerli RB, Reddy M, Koura AC, et al. Cystoscopy-assisted laparoscopic partial cystectomy. J Endourol 2008; 22:83.</a></li><li><a class="nounderline abstract_t">Fedele L, Bianchi S, Zanconato G, et al. Long-term follow-up after conservative surgery for bladder endometriosis. Fertil Steril 2005; 83:1729.</a></li><li><a class="nounderline abstract_t">Reisenauer C. Vesicovaginal fistulas: a gynecological experience in 41 cases at a German pelvic floor center. Arch Gynecol Obstet 2015; 292:245.</a></li><li><a class="nounderline abstract_t">Schonman R, Dotan Z, Weintraub AY, et al. Deep endometriosis inflicting the bladder: long-term outcomes of surgical management. Arch Gynecol Obstet 2013; 288:1323.</a></li><li><a class="nounderline abstract_t">Seracchioli R, Raimondo D, Di Donato N, et al. Histological evaluation of ureteral involvement in women with deep infiltrating endometriosis: analysis of a large series. Hum Reprod 2015; 30:833.</a></li><li><a class="nounderline abstract_t">Choi JI, Yoo JG, Kim SJ, et al. Acute Renal Failure due to Obstructive Uropathy Secondary to Ureteral Endometriosis. Case Rep Obstet Gynecol 2015; 2015:761348.</a></li><li><a class="nounderline abstract_t">Arrieta Bretón S, López Carrasco A, Hernández Gutiérrez A, et al. Complete loss of unilateral renal function secondary to endometriosis: a report of three cases. Eur J Obstet Gynecol Reprod Biol 2013; 171:132.</a></li><li><a class="nounderline abstract_t">Spinelli A, Contri S, Savino A, et al. Unexpected hypertension associated to silent renal failure in a "healthy" young woman. Intern Emerg Med 2014; 9:115.</a></li><li><a class="nounderline abstract_t">Freire MJ, Dinis PJ, Medeiros R, et al. Deep Infiltrating Endometriosis-Urinary Tract Involvement and Predictive Factors for Major Surgery. Urology 2017; 108:65.</a></li><li><a class="nounderline abstract_t">Pateman K, Holland TK, Knez J, et al. Should a detailed ultrasound examination of the complete urinary tract be routinely performed in women with suspected pelvic endometriosis? Hum Reprod 2015; 30:2802.</a></li><li><a class="nounderline abstract_t">Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr Radiol 1993; 23:478.</a></li><li><a class="nounderline abstract_t">Carmignani L, Vercellini P, Spinelli M, et al. Pelvic endometriosis and hydroureteronephrosis. Fertil Steril 2010; 93:1741.</a></li><li><a class="nounderline abstract_t">Shokeir AA, Provoost AP, Nijman RJ. Recoverability of renal function after relief of chronic partial upper urinary tract obstruction. BJU Int 1999; 83:11.</a></li><li><a class="nounderline abstract_t">Chapron C, Chiodo I, Leconte M, et al. Severe ureteral endometriosis: the intrinsic type is not so rare after complete surgical exeresis of deep endometriotic lesions. Fertil Steril 2010; 93:2115.</a></li><li><a class="nounderline abstract_t">Rivlin ME, Krueger RP, Wiser WL. Danazol in the management of ureteral obstruction secondary to endometriosis. Fertil Steril 1985; 44:274.</a></li><li><a class="nounderline abstract_t">Matsuura K, Kawasaki N, Oka M, et al. Treatment with danazol of ureteral obstruction caused by endometriosis. Acta Obstet Gynecol Scand 1985; 64:339.</a></li><li><a class="nounderline abstract_t">Gantt PA, Hunt JB, McDonough PG. Progestin reversal of ureteral endometriosis. Obstet Gynecol 1981; 57:665.</a></li><li><a class="nounderline abstract_t">Maccagnano C, Pellucchi F, Rocchini L, et al. Diagnosis and treatment of bladder endometriosis: state of the art. Urol Int 2012; 89:249.</a></li><li><a class="nounderline abstract_t">Vercellini P, Crosignani PG, Somigliana E, et al. Medical treatment for rectovaginal endometriosis: what is the evidence? Hum Reprod 2009; 24:2504.</a></li><li><a class="nounderline abstract_t">Seracchioli R, Mabrouk M, Manuzzi L, et al. Importance of retroperitoneal ureteric evaluation in cases of deep infiltrating endometriosis. J Minim Invasive Gynecol 2008; 15:435.</a></li><li><a class="nounderline abstract_t">Ghezzi F, Cromi A, Bergamini V, et al. Outcome of laparoscopic ureterolysis for ureteral endometriosis. Fertil Steril 2006; 86:418.</a></li><li><a class="nounderline abstract_t">Mereu L, Gagliardi ML, Clarizia R, et al. Laparoscopic management of ureteral endometriosis in case of moderate-severe hydroureteronephrosis. Fertil Steril 2010; 93:46.</a></li><li><a class="nounderline abstract_t">Carmignani L, Ronchetti A, Amicarelli F, et al. Bladder psoas hitch in hydronephrosis due to pelvic endometriosis: outcome of urodynamic parameters. Fertil Steril 2009; 92:35.</a></li><li><a class="nounderline abstract_t">Pérez-Utrilla Pérez M, Aguilera Bazán A, Alonso Dorrego JM, et al. Urinary tract endometriosis: clinical, diagnostic, and therapeutic aspects. Urology 2009; 73:47.</a></li><li><a class="nounderline abstract_t">Nezhat C, Nezhat F, Nezhat CH, et al. Urinary tract endometriosis treated by laparoscopy. Fertil Steril 1996; 66:920.</a></li><li><a class="nounderline abstract_t">Frenna V, Santos L, Ohana E, et al. Laparoscopic management of ureteral endometriosis: our experience. J Minim Invasive Gynecol 2007; 14:169.</a></li><li><a class="nounderline abstract_t">Seracchioli R, Manuzzi L, Mabrouk M, et al. A multidisciplinary, minimally invasive approach for complicated deep infiltrating endometriosis. Fertil Steril 2010; 93:1007.e1.</a></li><li><a class="nounderline abstract_t">Isac W, Kaouk J, Altunrende F, et al. Robot-assisted ureteroneocystostomy: technique and comparative outcomes. J Endourol 2013; 27:318.</a></li><li><a class="nounderline abstract_t">Scioscia M, Molon A, Grosso G, Minelli L. Laparoscopic management of ureteral endometriosis. Curr Opin Obstet Gynecol 2009; 21:325.</a></li><li><a class="nounderline abstract_t">Ahn M, Loughlin KR. Psoas hitch ureteral reimplantation in adults--analysis of a modified technique and timing of repair. Urology 2001; 58:184.</a></li><li><a class="nounderline abstract_t">Fedele L, Bianchi S, Zanconato G, et al. Is rectovaginal endometriosis a progressive disease? Am J Obstet Gynecol 2004; 191:1539.</a></li><li><a class="nounderline abstract_t">Mann WJ, Arato M, Patsner B, Stone ML. Ureteral injuries in an obstetrics and gynecology training program: etiology and management. Obstet Gynecol 1988; 72:82.</a></li><li><a class="nounderline abstract_t">Kobayashi E, Nagase T, Fujiwara K, et al. Total laparoscopic hysterectomy in 1253 patients using an early ureteral identification technique. J Obstet Gynaecol Res 2012; 38:1194.</a></li><li><a class="nounderline abstract_t">Magrina JF, Kho RM, Weaver AL, et al. Robotic radical hysterectomy: comparison with laparoscopy and laparotomy. Gynecol Oncol 2008; 109:86.</a></li><li><a class="nounderline abstract_t">Vercellini P, Meschia M, De Giorgi O, et al. Bladder detrusor endometriosis: clinical and pathogenetic implications. J Urol 1996; 155:84.</a></li><li class="breakAll">Berlanda N, Vercellini P. Endometriosis I. Surgery for endometriosis associated with pain. In: Reconstructive and Reproductive Surgery in Gynecology, 2nd ed, Munro MG, Gomel V (Eds), CRC Press, London  Vol 2, p.579.</li></ol></div><div id="topicVersionRevision">Topic 14190 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11119746" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Bladder endometriosis must be considered as bladder adenomyosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9591511" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Bladder endometriosis: deep infiltrating endometriosis or adenomyosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3369492" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Vesical endometriosis after cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12014052" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : [Bladder endometriosis in a patient with cesarean history].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12237623" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The pathogenesis of bladder detrusor endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26169038" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pathogenetic Mechanisms of Deep Infiltrating Endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19939297" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Ureteral and vesical endometriosis. Two different clinical entities sharing the same pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19837436" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10759279" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Is ureteral endometriosis an asymmetric disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20833638" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19481740" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Conservative laparoscopic management of urinary tract endometriosis (UTE): surgical outcome and long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9207609" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Definition of ureteral endometriosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21962747" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prevalence and management of urinary tract endometriosis: a clinical case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16882052" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Endometriosis of the urinary tract in women of reproductive age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23689345" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Ureteral endometriosis: proposal for a diagnostic and therapeutic algorithm with a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22534016" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Rectosigmoid deep infiltrating endometriosis and ureteral involvement with loss of renal function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11779587" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Ureteral endometriosis: a complication of rectovaginal endometriotic (adenomyotic) nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21621895" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The impact of deep disease on surgical treatment of endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25439849" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Urinary tract endometriosis in patients with deep infiltrating endometriosis: prevalence, symptoms, management, and proposal for a new clinical classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13791480" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Endometriosis of the urinary tract: a review of the literature and a report of four cases of vesical endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12796637" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Ureteral endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7251285" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Ureteral endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20656568" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Endometriosis of bladder: outcomes after laparoscopic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17498711" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Differences in characteristics among 1,000 women with endometriosis based on extent of disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24647161" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24366116" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Endometriosis: pathogenesis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25182151" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Urinary incontinence and bladder endometriosis: conservative management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14262046" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : CLINICALLY SIGNIFICANT ENDOMETRIOSIS OF THE URINARY TRACT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10799189" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bladder endometriosis: conservative management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27349699" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20489127" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Unusual manifestations and complications of endometriosis--spectrum of imaging findings: pictorial review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37792527" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The Diagnostic Accuracy of Transvaginal Ultrasound for Detection of Ureteral Involvement in Deep Infiltrating Endometriosis: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19017547" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Transvaginal ultrasound for diagnosis of deeply infiltrating endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24794315" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ultrasound mapping system for the surgical management of deep infiltrating endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29222825" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Outcome of sonography-based minimally invasive surgery for deep infiltrating endometriosis of the ureter and urinary bladder - a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33085096" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Accuracy of Transvaginal Ultrasound Compared to Cystoscopy in the Diagnosis of Bladder Endometriosis Nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18664469" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Diagnostic value of transvaginal 'tenderness-guided' ultrasonography for the prediction of location of deep endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23001892" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Prediction of pouch of Douglas obliteration in women with suspected endometriosis using a new real-time dynamic transvaginal ultrasound technique: the sliding sign.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27544308" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Surgery versus hormonal therapy for deep endometriosis: is it a choice of the physician?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20129993" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19467541" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Accuracy of magnetic resonance imaging for diagnosis and preoperative assessment of deeply infiltrating endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19924468" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Diagnosis of deep infiltrating endometriosis: accuracy of magnetic resonance imaging and transvaginal 3D ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20882634" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Magnetic resonance imaging in the evaluation of (deep infiltrating) endometriosis: the value of diffusion-weighted imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12372471" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Laparoscopic management of 15 patients with infiltrating endometriosis of the bladder and a case of primary intravesical endometrioid adenosarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22926841" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18177868" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28040358" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10577619" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Laparoscopic management of bladder endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12476526" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Endometriosis of the urinary tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16630689" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Clinical aspects and surgical treatment of urinary tract endometriosis: our experience with 31 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17361325" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Update on the diagnosis and treatment of bladder endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21036650" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : [Deep bladder endometriosis: how do I...to perform a laparoscopic partial cystectomy?].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12490020" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Cystoscopy-assisted laparoscopic resection of extramucosal bladder endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16698535" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Combined transurethral and laparoscopic partial cystectomy and robot-assisted bladder repair for the treatment of bladder endometrioma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18675963" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Transurethral partial cystectomy and laparoscopic reconstruction for the management of bladder endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18315479" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Cystoscopy-assisted laparoscopic partial cystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15950643" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Long-term follow-up after conservative surgery for bladder endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26001626" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Vesicovaginal fistulas: a gynecological experience in 41 cases at a German pelvic floor center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23778640" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Deep endometriosis inflicting the bladder: long-term outcomes of surgical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25586785" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Histological evaluation of ureteral involvement in women with deep infiltrating endometriosis: analysis of a large series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26345735" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Acute Renal Failure due to Obstructive Uropathy Secondary to Ureteral Endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24007623" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Complete loss of unilateral renal function secondary to endometriosis: a report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23715782" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Unexpected hypertension associated to silent renal failure in a "healthy" young woman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28694092" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Deep Infiltrating Endometriosis-Urinary Tract Involvement and Predictive Factors for Major Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26433965" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Should a detailed ultrasound examination of the complete urinary tract be routinely performed in women with suspected pelvic endometriosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8255658" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19200964" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Pelvic endometriosis and hydroureteronephrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10233446" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Recoverability of renal function after relief of chronic partial upper urinary tract obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19296947" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Severe ureteral endometriosis: the intrinsic type is not so rare after complete surgical exeresis of deep endometriotic lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4018283" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Danazol in the management of ureteral obstruction secondary to endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3895811" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Treatment with danazol of ureteral obstruction caused by endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6452593" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Progestin reversal of ureteral endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22813980" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Diagnosis and treatment of bladder endometriosis: state of the art.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19574277" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Medical treatment for rectovaginal endometriosis: what is the evidence?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18588850" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Importance of retroperitoneal ureteric evaluation in cases of deep infiltrating endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16764874" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Outcome of laparoscopic ureterolysis for ureteral endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18990377" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Laparoscopic management of ureteral endometriosis in case of moderate-severe hydroureteronephrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18692798" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Bladder psoas hitch in hydronephrosis due to pelvic endometriosis: outcome of urodynamic parameters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18950841" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Urinary tract endometriosis: clinical, diagnostic, and therapeutic aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8941055" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Urinary tract endometriosis treated by laparoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17368251" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Laparoscopic management of ureteral endometriosis: our experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19939374" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : A multidisciplinary, minimally invasive approach for complicated deep infiltrating endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22967284" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Robot-assisted ureteroneocystostomy: technique and comparative outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19512927" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Laparoscopic management of ureteral endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11489694" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Psoas hitch ureteral reimplantation in adults--analysis of a modified technique and timing of repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15547522" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Is rectovaginal endometriosis a progressive disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3380511" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Ureteral injuries in an obstetrics and gynecology training program: etiology and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22540927" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Total laparoscopic hysterectomy in 1253 patients using an early ureteral identification technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18279944" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Robotic radical hysterectomy: comparison with laparoscopy and laparotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7490905" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Bladder detrusor endometriosis: clinical and pathogenetic implications.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
